Previous Article | Next Article ![]()
Applied and Environmental Microbiology, November 2005, p. 7139-7144, Vol. 71, No. 11
0099-2240/05/$08.00+0 doi:10.1128/AEM.71.11.7139-7144.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Institut für Biotechnologie 1, Forschungszentrum Jülich, D-52425 Jülich, Germany
Received 12 April 2005/ Accepted 16 June 2005
|
|
|---|
197, encoding an L-serine-insensitive 3-phosphoglycerate dehydrogenase, yielded only traces of L-serine, as did the overexpression of these genes in a strain with the L-serine dehydratase gene sdaA deleted. However, reduced expression of the serine hydroxymethyltransferase gene glyA, in combination with the overexpression of serA
197, serC, and serB, resulted in a transient accumulation of up to 16 mM L-serine in the culture medium. When sdaA was also deleted, the resulting strain, C. glutamicum
sdaA::pK18mobglyA'(pEC-T18mob2serA
197CB), accumulated up to 86 mM L-serine with a maximal specific productivity of 1.2 mmol h1 g (dry weight)1. This illustrates a high rate of L-serine formation and also utilization in the C. glutamicum wild type. Therefore, metabolic engineering of L-serine production from glucose can be achieved only by addressing the apparent key position of this amino acid in the central metabolism. |
|
|---|
![]() View larger version (23K): [in a new window] |
FIG. 1. Scheme of L-serine biosynthesis and its metabolism in C. glutamicum during growth on glucose. Dotted arrows represent pathways consisting of more than one reaction. Genes are given in italics.
|
Since there is not yet a convincing strain for L-serine production from glucose, we met the challenge to engineer C. glutamicum for this purpose. In C. glutamicum as in other bacteria, L-serine is synthesized via phosphorylated intermediates starting with the glycolytic intermediate 3-phosphoglycerate, which is oxidized to phosphohydroxypyruvate. Subsequent transamination leads to the formation of phosphoserine, which is dephosphorylated to yield L-serine (Fig. 1). We have previously studied 3-phosphoglycerate dehydrogenase (PGDH; serA) from C. glutamicum catalyzing the initial reaction of the three-step pathway of L-serine biosynthesis (30). As a result of deleting the 197 carboxy-terminal amino acids of the SerA polypeptide, PGDH activity is no longer inhibited by L-serine (30). C. glutamicum possesses a high capacity to degrade L-serine in the presence of glucose, and we could demonstrate that sdaA-encoded L-serine dehydratase is involved in L-serine degradation (24). Based on these studies, we describe here the construction of an L-serine-producing strain from C. glutamicum by metabolic engineering.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Strains and plasmids used
|
Isolation of serine-auxotrophic mutants and localization of transposon insertion sites.
The transposon (Tn) delivery vector pCGL0040 was isolated from E. coli GM2929 grown in the presence of 50 µg of kanamycin and 20 µg of chloramphenicol ml1 (1). The plasmid was used to transform C. glutamicum ATCC 14752 to kanamycin resistance by using LBHIS plates (20) with 15 µg of kanamycin ml1. The resulting Tn mutants were transferred to CGXII plates containing 25 µg of kanamycin ml1 and either no peptide or a 3 mM concentration of the dipeptide Ser-Ala. Four clones that exhibited only growth in the presence of Ser-Ala were isolated. These clones were retrieved from the LBHIS master plate and tested on CGXII plates containing 25 µg of kanamycin ml1, 2 mM Ser-Ala, 1 mM L-serine, 1 mM L-alanine, or no supplement. Three mutants required Ser-Ala or L-serine for growth. The cloning and sequencing of the Tn insertion site in these mutants was performed as described previously (32).
Construction of plasmids and strains.
Plasmids were constructed in E. coli DH5
MCR from PCR-generated fragments (Expand High Fidelity PCR kit; Roche Diagnostics) by using C. glutamicum ATCC 13032 DNA as a template prepared according to a method described elsewhere (10). E. coli was transformed by the RbCl2 method (12) and C. glutamicum via electroporation (36). All transformants were analyzed by plasmid analysis and/or PCR with appropriate primers, respectively.
In order to construct pEC-T18mob2serCB, serC and serB were amplified by PCR using the upstream primers serC-upper (5'-GACCACCCACAGCCACCGTAATC-3'; the nucleotide (nt) corresponding to nt 877628 of NC003450 is underlined) and serB-upper (5'-GCGGCCGCGTTGATGATCCTTGGGGTTACG-3'; the nucleotide corresponding to nt 2671294 of NC003450 is underlined), respectively, and the respective reverse primers serC-lower (5'-GCGGCCGCTTTCCCGCATGTTGACTCCTTCTA-3'; the nucleotide corresponding to nt 875874 of NC003450 is underlined) and serB-lower (5'-GAAGGATCCTCGCTATGTGG-3'; the nucleotide corresponding to nt 2669483 of NC003450 is underlined). Boldfaced nucleotides correspond to the introduction of a NotI restriction site. The PCR fragments were blunted and cloned into the SmaI site of pUC18. The obtained plasmids, pUC18serC and pUC18serB, were digested with ScaI and NotI, and the inserts containing serC and serB were isolated and ligated together, resulting in plasmid pUC18serCB. The plasmid was digested with EcoRI and XbaI, and the serCB-containing insert obtained was ligated into EcoRI- and XbaI-treated pEC-T18mob2, resulting in plasmid pEC-T18mob2serCB.
To construct pEC-T18mob2serA
197CB, plasmid pUC18serA
197 (30) was digested with EcoRI and BamHI and the serA
197-containing insert obtained was blunted and ligated in EcoRI-linearized and blunted plasmid pEC-T18serCB.
In order to place the glyA gene in the chromosome of C. glutamicum under the control of the IPTG-inducible tac promoter, the respective strains were transformed via electroporation with the nonreplicative plasmid pK18mobglyA' to kanamycin resistance. Selection for kanamycin resistance was performed in the presence of 100 µM IPTG. The correct integration into the chromosome via homologous glyA sequences was verified by PCR with appropriate primer pairs and controls. The resulting mutants carried one intact copy of glyA under the control of the inducible tac promoter and one incomplete copy under its own promoter.
Enzyme assays.
Phosphoserine phosphatase activity was analyzed as previously described (3) by the determination of inorganic phosphate (Pi) released from phosphoserine. Assays were performed discontinuously in mixtures (100 µl) containing 20 mM Tris-HCl (pH 7.5), 1 mM MgCl2, and 5 mM phosphoserine. The reaction was stopped after 5 and 10 min by adding 10 µl of 0.2 M EDTA and placing it on ice. The amount of Pi released was determined with an EnzChek phosphate assay kit (Molecular Probes) as described previously.
Serine hydroxymethyltransferase was assayed discontinuously by the quantification of glycine formed from serine and 5,10-methylene tetrahydrofolate via high-performance liquid chromatrography as previously described (33).
3-Phosphoglycerate dehydrogenase activity was determined spectrophotometrically by the formation of NADH as described elsewhere (30).
|
|
|---|
Influence of the overexpression of the L-serine biosynthesis genes on L-serine accumulation.
We previously showed that truncation of serA from C. glutamicum by 197 amino acids at its C terminus (encoded by the serA
197 allele) provided a 3-phosphoglycerate dehydrogenase devoid of feedback inhibition by L-serine (30). Here, we studied whether overexpression of serA or serA
197 is sufficient to increase L-serine accumulation in the WT. Therefore, the strains WT(pZ1serA)(pEC-T18mob2) and WT(pZ1serA
197)(pEC-T18mob2) were grown in minimal medium with 220 mM glucose as the carbon source and the L-serine concentration in the culture medium was determined (Table 2). However, neither the overexpression of mutant serA
197 nor the WT allele yielded significant L-serine concentrations. Enzyme assays confirmed, for WT(pZ1serA) (pEC-T18mob2), a specific PGDH activity of 700 nmol (min mg)1 and for WT(pZ1serA
197) (pEC-T18mob2), a specific activity of 690 nmol (min mg)1 equivalent to an 8- to 10-fold overexpression compared to the WT (30).
|
View this table: [in a new window] |
TABLE 2. L-Serine accumulation of various C. glutamicum strains
|
197)(pEC-T18mob2serCB) were constructed. Surprisingly, also with these strains, no substantial L-serine accumulation occurred (Table 2).
Influence of deletion of sdaA on L-serine accumulation.
Based on the result that the overexpression of the serine biosynthetic genes is not sufficient for L-serine production and our previous observation of a significant contribution of sdaA-encoded L-serine dehydratase (L-SerDH) to L-serine degradation in C. glutamicum (24), we used the wild-type derivative containing the sdaA deletion (WT
sdaA) to assay for the influence of the overexpression of the L-serine biosynthetic genes serA, serA
197, serC, and serB on L-serine accumulation in this background (Table 2). The control strain WT
sdaA(pZ1)(pEC-T18mob2) accumulated 0.08 mM L-serine after 28 h of cultivation and <0.05 mM after 54 h, showing that at the early time point, sdaA deletion alone resulted in traces of L-serine. C. glutamicum WT
sdaA(pZ1serA)(pEC-T18mob2serCB) accumulated 0.09 mM L-serine after 24 h and up to 0.15 mM after 54 h, showing a slight increase in L-serine accumulation compared to the control. However, with strain WT
sdaA(pZ1serA
197)(pEC-T18mob2serCB), 0.44 mM (28 h) and 0.14 mM (54 h) L-serine concentrations were determined. This comparison shows an advantage of the serA
197 allele over serA but that, despite the deletion of sdaA, degradation of L-serine is still occurring.
Influence of reduced serine hydroxymethyltransferase activity on L-serine accumulation.
In growing C. glutamicum, only 16% of the L-serine synthesized is incorporated into protein (21) whereas the remainder is cleaved by serine hydroxymethyltransferase (SHMT; glyA) to provide 5,10-methylene tetrahydrofolate and glycine. A reduced activity of SHMT was already shown to be favorable for L-threonine production with C. glutamicum due to an L-threonine-degrading side activity of the enzyme. Since the glyA gene could not be deleted or disrupted in C. glutamicum, even when supplemented with glycine (33), plasmid pK18mobglyA' was employed to reduce the SHMT activity by replacing the native glyA promoter with the IPTG-inducible tac promoter (33). We used strain WT::pK18mobglyA' to analyze the influence of a reduced SHMT activity on L-serine production. In the first experiments, this strain already accumulated up to 1 mM L-serine (not shown), illustrating the principal importance of SHMT reduction for L-serine accumulation. In order to overexpress serA
197 together with serC and serB in the kanamycin-resistant strain WT::pK18mobglyA', all three genes were cloned into vector pEC-T18mob2 (35) to generate pEC-T18serA
197CB (see Materials and Methods). Using this tetracycline resistance-conferring plasmid, strain WT::pK18mobglyA'(pEC-T18serA
197CB) was generated.
This strain was cultivated with or without 100 µM IPTG in minimal medium CGXII containing 220 mM glucose as the carbon source. Whereas in the presence of IPTG, the SHMT activity was 40 nmol min1 mg (protein)1, it was 10 nmol min1 mg (protein)1 without IPTG, confirming the successful application of pK18mobglyA'. With IPTG, L-serine accumulation was below 1 mM (not shown), but in the absence of the inducer, up to 16 mM L-serine accumulated (Fig. 2). Rate calculations showed that constant specific productivities of about 0.4 mmol h1 g (dry weight)1 occurred within 8 to 20 h of the cultivation. However, almost all L-serine was degraded again, which is consistent with our prior finding of the strong utilization of externally added L-serine by C. glutamicum unless L-SerDH (sdaA) was deleted (24).
![]() View larger version (23K): [in a new window] |
FIG. 2. Growth ( ), glucose ( ) and L-serine () concentrations in the medium, and specific L-serine productivity ( ) of strain WT::pK18mobglyA'(pEC-T18mob2serA 197CB) on minimal medium with 220 mM glucose. OD600, optical density at 600 nm; dw, dry weight.
|
sdaA as well as plasmid pEC-T18mob2serA
197CB to overexpress the L-serine biosynthesis genes. The resulting strain, WT
sdaA::pK18mobglyA'(pEC-T18mob2serA
197CB), was cultivated on CGXII medium with 220 mM glucose as the carbon source. In order to reduce glyA expression, IPTG was omitted. Enzyme activity determinations confirmed the expected low SHMT activity (not shown). A typical cultivation profile is shown in Fig. 3. L-Serine accumulated up to about 86 mM in the culture medium, with a maximum specific productivity of 1.2 mmol h1 g (dry weight)1 at about 20 h and a molar yield (YP/S) of 0.64 mol/mol. This confirmed the positive effect of sdaA deletion, which was also visible, although at a drastically reduced level when just the L-serine biosynthesis genes were overexpressed, without reducing SHMT activity (see above). Despite the efficient L-serine production with strain WT
sdaA::pK18mobglyA'(pEC-T18mob2serA
197CB), there was still significant degradation of L-serine at later time points (Fig. 3). A comparison of the growth rates of the different genetically modified strains with that of the wild type revealed that overexpression of the genes serA
197, serC, and serB alone or in combination with a deletion of the sdaA gene resulted in a decreased growth rate (Table 3). The largest reduction of growth rate was observed as a consequence of reduced glyA expression. The strains WT::pK18mobglyA'(pEC-T18mob2serA
197CB) and WT
sdaA::pK18mobglyA'(pEC-T18mob2serA
197CB) exhibited three- to fourfold-decreased growth rates under production conditions compared to the wild type and a twofold rate compared to the respective strains without reduced glyA expression (Table 3). This corroborates our previous finding that a reduced SHMT activity correlates with a reduced growth rate (33).
![]() View larger version (24K): [in a new window] |
FIG. 3. Growth ( ), glucose ( ) and L-serine () concentrations in the medium, and specific L-serine productivity ( ) of strain WT sdaA::pK18mobglyA'(pEC-T18mob2serA 197CB) on minimal medium with 220 mM glucose. OD600, optical density at 600 nm; dw, dry weight.
|
|
View this table: [in a new window] |
TABLE 3. Comparison of L-serine fluxesa in recombinant C. glutamicum strains
|
|
|
|---|
The wild-type serA derivative and the serA
197 allele were overexpressed either alone or in combination with the genes serB and serC, but L-serine accumulated only in traces not exceeding 0.1 mM. This distinguishes L-serine accumulation from, for instance, L-lysine formation by C. glutamicum, where deregulation of the initial enzyme of the pathway already results in substantial L-lysine accumulation of around 40 mM (4), indicating that intracellular L-serine turnover precludes its production. This is corroborated by our findings that L-serine production was high only when glyA expression was reduced and L-serine dehydratase activity absent. The corresponding strain WT
sdaA::pK18mobglyA'(pEC-T18mob2serA
197CB) accumulated L-serine up to 86 mM, which is in the same range as that observed for L-threonine accumulation with a respective threonine-producing C. glutamicum strain (33). Moreover, this strain produced a yield of 0.64 mol L-serine per mol glucose, which is about two- to sixfold higher than that obtained with processes where glycine or glycine plus methanol were used as substrates (16, 19). However, the reduced glyA expression in the L-serine-producing strain led to a slower growth rate and a lower final optical density compared to a strain with native glyA expression likely due to perturbation of the C-1 metabolism. Moreover, since the deletion of sdaA alone or in combination with overexpression of the L-serine biosynthetic genes did not result in an appreciable L-serine accumulation, it is inconclusive whether a significant intracellular flux increase due to the overexpression of the serA alleles together with serB and serC is present. These results denote that the L-serine pathway is a rather unusual amino acid biosynthesis pathway. This idea is supported by the atypical PGDH (serA) inhibition of C. glutamicum (30) and the facts that the equilibrium of the PGDH-catalyzed reaction is on the substrate side (34) and an ACT domain is present in PSP (serB).
Nevertheless, reduction of the glyA-encoded SHMT activity had clearly the major impact on L-serine accumulation. Already, the reduction of glyA expression alone resulted in an approximate 1 mM accumulation of L-serine (not shown), which was not the case upon sdaA deletion. The importance of reduced SHMT activity is also evident when comparing the maximal fluxes rates (Table 3). With SHMT reduction and overexpression of the biosynthesis pathway genes, the growth rate was 0.11 h1. The calculated flux over the pathway to satisfy the need for cellular synthesis, like phospholipid synthesis and C1 generation under these conditions, is 2.75 nmol min1 mg (dry weight)1 (22). Taking a maximal L-serine excretion rate of 10 nmol min1 mg (dry weight)1 into account (Fig. 2), a total L-serine flux of 12.75 nmol min1 mg (dry weight)1 resulted (Table 3). Importantly, the comparison of this strain with the WT and WTDsdaA (pEC-T18mob2serA
197CB) illustrates that reducing the L-serine degradation to glycine and C1 units favors an increased total L-serine flux, indicative of a stimulation of the L-serine synthesis probably due to a reduced availability of glycine and C1 units (Table 3). The strong increase in L-serine flux by 11.02 to 23.75 nmol min1 mg (dry weight)1 due to the additional sdaA deletion in WTDsdaA::pK18mobglyA' (pEC-T18mob2serA
197CB) is largely in agreement with the difference in the L-serine degradation rates observed for the wild type and its sdaA deletion mutant with externally added L-serine where the sdaA deletion caused a decrease in L-serine degradation by 7.7 nmol min1 mg (dry weight)1 (24). This work demonstrates that engineering L-serine production from glucose requires considering the position of L-serine in metabolism instead of considering L-serine as an end product of a biosynthetic pathway.
This work was supported in part by the Deutsche Bundesstiftung Umwelt (DBU AZ13037 and AZ13089).
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»